Tripos Discovery Research Ltd. (TRPS), a Subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), Announces Name Change to Exelgen, Ltd.  
11/29/2007 9:39:17 AM

RICHMOND, Va. & BUDE, England--(BUSINESS WIRE)--Tripos Discovery Research Limited (TDR), a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ Capital Market: CBTE) and a leading provider of drug discovery chemistry services and small molecule products, announces today that it has changed its name to Exelgen, Ltd.